II. Epidemiology
- Rare disease seen most often in men
III. Pathophysiology
- Similar to Classic Polyarteritis Nodosa
- Small Vessel, Granulomatous Vasculitis
- Multiple organ system involvement
- Interstitial Lung Disease
IV. Phases
- Phase 1: Prodromal (esp. Upper Respiratory)
- Phase 2: Eosinophilic (esp. Lower Respiratory)
- Eosinophilic lung infiltrate
- Phase 3: Vasculitis (occurs within 3 years of onset)
- Granulomatous ANCA-associated Small Vessel Vasculitis
V. Signs: Interstitial Lung Disease
- Eosinophilic tissue infiltration
VI. Labs
-
Antineutrophil Cytoplasmic Antibody (ANCA)
- Positive in 70% of cases (usually MPO-ANCA)
-
Complete Blood Count (CBC)
- Eosinophilia >10%
VII. Complications (often cause of death)
- Coronary arteritis
- Myocarditis
VIII. Differential Diagnosis
- Polyarteritis Nodosa (medium vessel Vasculitis)
-
ANCA-Associated Small Vessel Vasculitis
- Granulomatosis with Polyangiitis (previously known as Wegener's Granulomatosis)
- Microscopic Polyangiitis
IX. Management
- High-dose Corticosteroids
- Control vascular injury
X. References
- Calabrese in Ruddy (2001) Kelly's Rheum, p. 1179-81
- Eustace (1999) J Am Soc Nephrol 10(9):2048-55 [PubMed]